• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 521245 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416761282 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416761282 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Investors look to Lighten Up on Shares of Pacific Biosciences of California , Shares Down 6.8% (PACB)

Published on Fri, 06/21/2013 - 12:28
By Adrienne Chilton

Pacific Biosciences of California (NASDAQ:PACB) is one of today's worst performing low-priced stocks, down 6.8% to $2.47 on 1.1x average daily volume. Thus far today, Pacific Biosciences of California has traded 477,000 shares, vs. average volume of 453,000 shares per day. The stock has underperformed the Dow (-6.8% to the Dow's 0.3%) and underperformed the S&P 500 (-6.8% to the S&P's 0.2%) during today's trading.

Pacific Biosciences of California Inc. has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. The Company's system enables real-time analysis of biomolecules with single molecule resolution.

In the past 52 weeks, Pacific Biosciences of California share prices have been bracketed by a low of $1.06 and a high of $3.25 and are now at $2.47, 133% above that low price. The 200-day and 50-day moving averages have moved 0.87% higher and 1.56% higher over the past week, respectively.

Potential upside of 6.6% exists for Pacific Biosciences of California , based on a current level of $2.47 and analysts' average consensus price target of $2.63. The stock should hit resistance at its 50-day moving average (MA) of $2.52, as well as support at its 200-day MA of $2.09.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Post Earnings Update: International Pape...

When International Paper (NYSE:IP) reported earnings two weeks ago on November 4th, 201 ...

Protective Life Earnings Review: 19 Days...

Two weeks ago on November 3rd, 2014 Protective Life (NYSE:PL) reported earnings and ana ...

Earnings Look Back: Estee Lauder Is Up 1...

18 days ago, on November 4th, 2014, Estee Lauder (NYSE:EL) reported its earnings. Anal ...

Delek US Holdings Earnings Review: 17 Da...

When Delek US Holdings (NYSE:DK) reported earnings two weeks ago on November 5th, 2014, ...

Earnings Look Back: Stifel Financial Is ...

When Stifel Financial (NYSE:SF) reported earnings two weeks ago on November 6th, 2014, ...

Post Earnings Update: Dean Foods Has Cli...

A week ago on November 10th, 2014 Dean Foods (NYSE:DF) reported earnings and analysts, ...

Earnings Look Back: CF Industries Is Up ...

When CF Industries (NYSE:CF) reported earnings two weeks ago on November 5th, 2014, ana ...

Spectra Energy Earnings Hindsight: Up 0....

When Spectra Energy (NYSE:SE) reported earnings 17 days ago on November 5th, 2014, anal ...